This Federal Public Health Grant aims to establish a sustainable network of US institutions. The primary purpose is to collect hospitalization data and generate accurate annual estimates of influenza vaccine effectiveness (VE) in preventing influenza-associated hospitalizations among US adult populations. Participating institutions will collaboratively enroll adult hospitalized patients suffering from acute respiratory illness. Influenza infection will be confirmed using advanced laboratory-based molecular assays. The overall effectiveness of the vaccine will then be precisely estimated utilizing a robust test-negative study design. This initiative is crucial for enhancing public health surveillance and informing vaccine policy.
Opportunity ID: 271409
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-002 |
| Funding Opportunity Title: | US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Jan 13, 2015 |
| Last Updated Date: | Jan 30, 2015 |
| Original Closing Date for Applications: | Mar 03, 2015 |
| Current Closing Date for Applications: | Mar 03, 2015 |
| Archive Date: | Apr 02, 2015 |
| Estimated Total Program Funding: | $11,600,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | $275,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility Category: State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits Other Than Institutions of Higher Education: Nonprofits (Other than Institutions of Higher Education) Governments: Eligible Agencies of the Federal Government U.S. Territory or Possession Other: Native American tribal organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations Bona Fide Agents: a Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via www.grants.gov. Foreign Organizations are not eligible to apply. Foreign components of U.S. Organizations are not eligible to apply. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The goal of this funding announcement is to establish a sustainable network of US institutions that can obtain hospitalization data and provide accurate estimates of annual influenza vaccine effectiveness (VE) to preventinfluenza-associated hospitalizations in US adult populations. Participating institutions will coordinate enrollment of adult hospitalized patients with acute respiratory illness (ARI), confirm influenza infection using sensitive laboratory-based molecular assays, and estimate VE using a test-negative study design. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Phone: 770-488-2700 Email:pgotim@cdc.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Amendment 1. Summary of conference call. Q&A’s. | Jan 30, 2015 | |
| Jun 18, 2016 | ||
| Jun 18, 2016 | ||
| Jun 18, 2016 | ||
| Additional CFDA # | Jan 30, 2015 | |
| Jan 13, 2015 |
DISPLAYING: Synopsis 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-002 |
| Funding Opportunity Title: | US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 3 |
| Posted Date: | Jan 13, 2015 |
| Last Updated Date: | Jan 30, 2015 |
| Original Closing Date for Applications: | Mar 03, 2015 |
| Current Closing Date for Applications: | Mar 03, 2015 |
| Archive Date: | Apr 02, 2015 |
| Estimated Total Program Funding: | $11,600,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | $275,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility Category: State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits Other Than Institutions of Higher Education: Nonprofits (Other than Institutions of Higher Education) Governments: Eligible Agencies of the Federal Government U.S. Territory or Possession Other: Native American tribal organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations Bona Fide Agents: a Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via www.grants.gov. Foreign Organizations are not eligible to apply. Foreign components of U.S. Organizations are not eligible to apply. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The goal of this funding announcement is to establish a sustainable network of US institutions that can obtain hospitalization data and provide accurate estimates of annual influenza vaccine effectiveness (VE) to preventinfluenza-associated hospitalizations in US adult populations. Participating institutions will coordinate enrollment of adult hospitalized patients with acute respiratory illness (ARI), confirm influenza infection using sensitive laboratory-based molecular assays, and estimate VE using a test-negative study design. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Phone: 770-488-2700 Email:pgotim@cdc.gov |
DISPLAYING: Forecast 3
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-002 |
| Funding Opportunity Title: | US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated Hospitalizations |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Forecast 3 |
| Posted Date: | Jun 18, 2016 |
| Last Updated Date: | Jun 18, 2016 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | – |
| Archive Date: | Apr 02, 2015 |
| Estimated Total Program Funding: | $11,600,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | $275,000 |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses County governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Special district governments Independent school districts |
| Additional Information on Eligibility: | a) Research proposed under this funding opportunity announcement may not overlap with research activities simultaneously funded under Optional Objective A: Inpatient MAARI VE Evaluation of FOA IP11-003: Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Influenza in the United States and should so state in the applicaiton. b) Applicant institutions or applicant institutions that propose contract services with institutions or organizations that do not currently have a high frequency of clinical testing (goal: >65% of admitted patients with symptoms consistent with ARI) are eligible to apply but must include the following detail in the application: A plan to identify, enroll, and collect a respiratory specimen on patients with ARI within 48-72 hours of admission; Participation levels of >50% in previous studies enrolling >150 hospitalized adult patients; Ability to enroll the sample size(s) identified in Part 2. Section I.2.Approach (after accounting for participation). c) Eligibility for Optional Component funding will be limited to those applications recommended for funding of the Core Component. To be considered for Optional Component funding, the Optional Component application must have an overall priority score between 10 and 50. |
Additional Information
| Agency Name: | – |
| Description: | Purpose: Influenza is an important cause of morbidity, mortality, and healthcare burden across all age groups. Because influenza viruses are constantly changing and vaccines are reformulated every year, annual estimates of the effectiveness of influenza vaccines in preventing influenza infection and its associated complications are needed in order to evaluate the protection provided by annual, nationwide vaccination programs. The goal of this funding opportunity announcement is to establish a sustainable network of US institutions that can obtain hospitalization data and provide accurate estimates of annual influenza Vaccine Effectiveness (VE) so as to mitigate and prevent influenza-associated hospitalizations in US adult populations. Participating institutions will coordinate enrollment of adult hospitalized patients with influenza infection, confirm influenza infection status using sensitive laboratory-based molecular assays, and estimate VE using a test-negative study design. Annual VE estimates will be used to inform and assess the public health impact of influenza vaccination programs on the prevention of health-related complications due to influenza infection, especially in older adults. In addition, and as research data on VE becomes available, this network will allow comparison of VE data for specific vaccine types available in the US and provide service as an emergency response resource in the event of an influenza pandemic. Results from research under this funding opportunity should yield high impact public health findings and/or strategies that will contribute to a reduction in overall burden to healthcare and improve the health of the US population. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:zcq8@cdc.gov |
DISPLAYING: Forecast 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-002 |
| Funding Opportunity Title: | US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated Hospitalizations |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Forecast 2 |
| Posted Date: | Jun 18, 2016 |
| Last Updated Date: | Jun 18, 2016 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | – |
| Archive Date: | Apr 02, 2015 |
| Estimated Total Program Funding: | $11,600,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | $275,000 |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses County governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Special district governments Independent school districts |
| Additional Information on Eligibility: | a) Research proposed under this funding opportunity announcement may not overlap with research activities simultaneously funded under Optional Objective A: Inpatient MAARI VE Evaluation of FOA IP11-003: Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Influenza in the United States and should so state in the applicaiton. b) Applicant institutions or applicant institutions that propose contract services with institutions or organizations that do not currently have a high frequency of clinical testing (goal: >65% of admitted patients with symptoms consistent with ARI) are eligible to apply but must include the following detail in the application: A plan to identify, enroll, and collect a respiratory specimen on patients with ARI within 48-72 hours of admission; Participation levels of >50% in previous studies enrolling >150 hospitalized adult patients; Ability to enroll the sample size(s) identified in Part 2. Section I.2.Approach (after accounting for participation). c) Eligibility for Optional Component funding will be limited to those applications recommended for funding of the Core Component. To be considered for Optional Component funding, the Optional Component application must have an overall priority score between 10 and 50. |
Additional Information
| Agency Name: | – |
| Description: | Purpose: Influenza is an important cause of morbidity, mortality, and healthcare burden across all age groups. Because influenza viruses are constantly changing and vaccines are reformulated every year, annual estimates of the effectiveness of influenza vaccines in preventing influenza infection and its associated complications are needed in order to evaluate the protection provided by annual, nationwide vaccination programs. The goal of this funding opportunity announcement is to establish a sustainable network of US institutions that can obtain hospitalization data and provide accurate estimates of annual influenza Vaccine Effectiveness (VE) so as to mitigate and prevent influenza-associated hospitalizations in US adult populations. Participating institutions will coordinate enrollment of adult hospitalized patients with influenza infection, confirm influenza infection status using sensitive laboratory-based molecular assays, and estimate VE using a test-negative study design. Annual VE estimates will be used to inform and assess the public health impact of influenza vaccination programs on the prevention of health-related complications due to influenza infection, especially in older adults. In addition, and as research data on VE becomes available, this network will allow comparison of VE data for specific vaccine types available in the US and provide service as an emergency response resource in the event of an influenza pandemic. Results from research under this funding opportunity should yield high impact public health findings and/or strategies that will contribute to a reduction in overall burden to healthcare and improve the health of the US population. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:zcq8@cdc.gov |
DISPLAYING: Forecast 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-002 |
| Funding Opportunity Title: | US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-Associated Hospitalizations |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.083 — Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases |
| Cost Sharing or Matching Requirement: | No |
| Version: | Forecast 1 |
| Posted Date: | Jun 18, 2016 |
| Last Updated Date: | Jun 18, 2016 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | – |
| Archive Date: | Mar 14, 2015 |
| Estimated Total Program Funding: | $6,000,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | $275,000 |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility” Native American tribal governments (Federally recognized) For profit organizations other than small businesses State governments City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses County governments Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Special district governments Independent school districts |
| Additional Information on Eligibility: | No Foreign Applicants |
Additional Information
| Agency Name: | – |
| Description: | Purpose: Influenza is an important cause of morbidity, mortality, and healthcare burden across all age groups. Because influenza viruses are constantly changing and vaccines are reformulated every year, annual estimates of the effectiveness of influenza vaccines in preventing influenza infection and its associated complications are needed in order to evaluate the protection provided by annual, nationwide vaccination programs. The goal of this funding opportunity announcement is to establish a sustainable network of US institutions that can obtain hospitalization data and provide accurate estimates of annual influenza Vaccine Effectiveness (VE) so as to mitigate and prevent influenza-associated hospitalizations in US adult populations. Participating institutions will coordinate enrollment of adult hospitalized patients with influenza infection, confirm influenza infection status using sensitive laboratory-based molecular assays, and estimate VE using a test-negative study design. Annual VE estimates will be used to inform and assess the public health impact of influenza vaccination programs on the prevention of health-related complications due to influenza infection, especially in older adults. In addition, and as research data on VE becomes available, this network will allow comparison of VE data for specific vaccine types available in the US and provide service as an emergency response resource in the event of an influenza pandemic. Results from research under this funding opportunity should yield high impact public health findings and/or strategies that will contribute to a reduction in overall burden to healthcare and improve the health of the US population. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
–
Email:zcq8@cdc.gov |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-002 |
| Funding Opportunity Title: | US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Jan 30, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 03, 2015 |
| Archive Date: | Apr 02, 2015 |
| Estimated Total Program Funding: | $11,600,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | $275,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility Category: State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits Other Than Institutions of Higher Education: Nonprofits (Other than Institutions of Higher Education) Governments: Eligible Agencies of the Federal Government U.S. Territory or Possession Other: Native American tribal organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations Bona Fide Agents: a Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via www.grants.gov. Foreign Organizations are not eligible to apply. Foreign components of U.S. Organizations are not eligible to apply. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The goal of this funding announcement is to establish a sustainable network of US institutions that can obtain hospitalization data and provide accurate estimates of annual influenza vaccine effectiveness (VE) to prevent influenza-associated hospitalizations in US adult populations. Participating institutions will coordinate enrollment of adult hospitalized patients with acute respiratory illness (ARI), confirm influenza infection using sensitive laboratory-based molecular assays, and estimate VE using a test-negative study design. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Phone: 770-488-2700 Email:pgotim@cdc.gov |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-IP-15-002 |
| Funding Opportunity Title: | US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | 4 |
| Assistance Listings: | 93.185 — Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 13, 2015 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Mar 03, 2015 |
| Archive Date: | Apr 02, 2015 |
| Estimated Total Program Funding: | $11,600,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | $275,000 |
Eligibility
| Eligible Applicants: | Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Eligibility Category: State governments County governments City or township governments Special district governments Independent school districts Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education For profit organizations other than small businesses Small businesses The following types of Higher Education Institutions are always encouraged to apply for CDC support as Public or Private Institutions of Higher Education: Hispanic-serving Institutions Historically Black Colleges and Universities (HBCUs) Tribally Controlled Colleges and Universities (TCCUs) Alaska Native and Native Hawaiian Serving Institutions Nonprofits Other Than Institutions of Higher Education: Nonprofits (Other than Institutions of Higher Education) Governments: Eligible Agencies of the Federal Government U.S. Territory or Possession Other: Native American tribal organizations (other than Federally recognized tribal governments) Faith-based or Community-based Organizations Regional Organizations Bona Fide Agents: a Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment Forms" when submitting via www.grants.gov. Foreign Organizations are not eligible to apply. Foreign components of U.S. Organizations are not eligible to apply. |
Additional Information
| Agency Name: | Centers for Disease Control and Prevention – ERA |
| Description: | The goal of this funding announcement is to establish a sustainable network of US institutions that can obtain hospitalization data and provide accurate estimates of annual influenza vaccine effectiveness (VE) to prevent influenza-associated hospitalizations in US adult populations. Participating institutions will coordinate enrollment of adult hospitalized patients with acute respiratory illness (ARI), confirm influenza infection using sensitive laboratory-based molecular assays, and estimate VE using a test-negative study design. |
| Link to Additional Information: | – |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
Centers for Disease Control and Prevention (CDC)
Procurement and Grants Office (PGO) Phone: 770-488-2700 Email:pgotim@cdc.gov |
Related Documents
Folder 271409 Full Announcement-1 -> RFA-IP15-002 Amendment 1.pdf
Packages
| Agency Contact Information: | Centers for Disease Control and Prevention (CDC) Procurement and Grants Office (PGO) Phone: 770-488-2700 Email: pgotim@cdc.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| 93.185 | RFA-IP-15-002 | US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated | PKG00211683 | Jan 13, 2015 | Mar 03, 2015 | View |
Package 1
Mandatory forms
271409 RR_SF424_2_0-2.0.pdf
271409 PHS398_ResearchPlan_2_0-2.0.pdf
271409 PHS398_CoverPageSupplement_2_0-2.0.pdf
271409 RR_Budget_1_3-1.3.pdf
271409 RR_KeyPersonExpanded_2_0-2.0.pdf
271409 RR_OtherProjectInfo_1_3-1.3.pdf
271409 PerformanceSite_2_0-2.0.pdf
Optional forms
271409 PlannedReport-1.0.pdf
271409 PHS398_CumulativeInclusionReport-1.0.pdf
271409 RR_SubawardBudget30_1_3-1.3.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
